Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Nimer

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Nature Medicine|February 1, 1997
Platelet stimulating agents--off the launching padS D Nimer
Blood|January 13, 1999
Essential thrombocythemia: another "heterogeneous disease" better understood?S D Nimer
Cancer|August 15, 1992
The use of colony-stimulating factors in primary hematologic disordersS D Nimer
Leukemia & Lymphoma|January 1, 1994
Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis XL Chap, S D Nimer
Leukemia Research|March 28, 2002
Mutations in human cancer: how close should we look?J Cammenga, S D Nimer
Stem Cells (Dayton, Ohio)|July 1, 1995
Regulation of granulocyte-macrophage colony-stimulating factor and interleukin 3 expressionS D Nimer, H Uchida
Blood|December 15, 1992
Transcription factors, translocations, and leukemiaJ Nichols, S D Nimer
Seminars in Hematology|July 31, 1998
The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopeniaP Maslak, S D Nimer
Cancer Treatment and Research|January 1, 1990
Therapeutic use of hematopoietic growth factors in bone marrow transplantationS D Nimer, R E Champlin
Leukemia|March 11, 2014
Chromatin modifiers and the promise of epigenetic therapy in acute leukemiaS M Greenblatt, S D Nimer
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Nature Medicine|February 1, 1997
Platelet stimulating agents--off the launching padS D Nimer
Blood|January 13, 1999
Essential thrombocythemia: another "heterogeneous disease" better understood?S D Nimer
Cancer|August 15, 1992
The use of colony-stimulating factors in primary hematologic disordersS D Nimer
Leukemia & Lymphoma|January 1, 1994
Chronic myelogenous leukemia following repeated radiation therapy for histiocytosis XL Chap, S D Nimer
Leukemia Research|March 28, 2002
Mutations in human cancer: how close should we look?J Cammenga, S D Nimer
Stem Cells (Dayton, Ohio)|July 1, 1995
Regulation of granulocyte-macrophage colony-stimulating factor and interleukin 3 expressionS D Nimer, H Uchida
Blood|December 15, 1992
Transcription factors, translocations, and leukemiaJ Nichols, S D Nimer
Seminars in Hematology|July 31, 1998
The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopeniaP Maslak, S D Nimer
Cancer Treatment and Research|January 1, 1990
Therapeutic use of hematopoietic growth factors in bone marrow transplantationS D Nimer, R E Champlin
Leukemia|March 11, 2014
Chromatin modifiers and the promise of epigenetic therapy in acute leukemiaS M Greenblatt, S D Nimer
Pageof 9